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Does Benzene Cause Multiple Myeloma?
An Analysis ofthe Published Case-Control
Literature
Shewit Bezabeh, Arnold Engel, Carolyn B. Morris,
and Steven H. Lamm
Consultants in Epidemiology and Occupational Health, Washington, DC
Two case series and two epidemiological studies in the 1970s and 1980s suggested that
benzene exposure might be a risk factor for multiple myeloma. An analysis has now been
conducted of the published population-based and hospital-based case-control studies published
through mid-1995 that permit examination of the relationship between multiple myeloma and
benzene exposure or surrogates for benzene exposure. No increased association was found
between multiple myeloma and benzene exposure or exposure to chemical groups that included
benzene. The odds ratios from these analyses approximated 1.0. Exposures to petroleum
products and employment in petroleum-related occupations did not appear to be risk factors for
multiple myeloma. Cigarette smoking, as a surrogate of benzene exposure, was not found to be
associated with multiple myeloma, while some studies of products of combustion described as
"engine exhaust" did show a significant association with multiple myeloma. In toto, the
population-based and hospital-based case-control literature indicated that benzene exposure was
not a likely causal factor for multiple myeloma. - Environ Health Perspect 104(Suppl
6):1393-1398 (1996)
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Introduction
Does benzene cause multiple myeloma? In
1990, Goldstein (1) argued that
it is reasonable, although not scientific-
ally proven, to causally relate benzene
exposure to multiple myeloma. The evi-
dence remains less than definitive in that
the level ofproof ofsuch a relationship
does not meet that required for a state-
ment ofscientific certainty, although it
is rapidly approaching this point.
The evidence then consisted of a few case
series ofbenzene-exposed multiple myeloma
cases and of cases in a few epidemiological
studies of benzene-exposed workers. The
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first two case reports ofmultiple myeloma
in benzene-exposed workers were from
Torres et al. (2) in 1970. A subsequent
report offour cases came from Aksoy et al.
(3) in 1984. The first report of multiple
myeloma cases in an epidemiological study
of benzene-exposed workers was from
Decoufle et al. (4) in 1983, and the first
(and only) report ofa statistically significant
excess ofmultiple myeloma in a cohort of
benzene-exposed workers was from Rinsky
et al. (5) in 1987. Although the four multi-
ple myeloma cases reported by Rinsky et al.
in 1987 represented a statistically signifi-
cant excess in his analysis ofOhio Pliofilm
worker mortality through 1981, the subse-
quent analysis of mortality through 1987
(6) found that the mortality risk for multi-
ple myeloma no longer showed a statisti-
cally significant elevation. These earlier
studies were sufficient to raise the hypothe-
sis that benzene exposure was a risk factor
for multiple myeloma but not to test that
hypothesis. The current report contains an
analysis of the published population-based
and hospital-based case-control studies to
test that hypothesis.
Multiple myeloma is one of the neo-
plasms ofthe lymphatic and hematopoietic
system. It is a malignant tumor of the
plasma cell that is derived from B lympho-
cytes and located primarily in the bone
marrow. It is differentiated from Hodgkin's
and non-Hodgkin's lymphomas and from
the leukemias. Previous analysis has demon-
strated that acute myelogenous leukemia
(AML) and its variants are consistently asso-
ciated with benzene exposure but that the
other leukemias are not (7). This report
examines whether multiple myeloma and
benzene exposure areconsistently associated.
Methods and Materials
StudyDesignandBase
The epidemiological literature examining
whether a specific risk factor (exposure) and
a specific disease (outcome) are associated
consists ofcohort studies and case-control
studies. In the cohort studies, persons with
the exposure and persons without the expo-
sure are followed forward in time to observe
the comparative frequencies ofspecific dis-
eases (or causes ofdeath) among them. In
the case-control studies, the histories of
persons with the disease and of persons
without the disease are examined for the
comparative frequencies ofprior exposures
to various possible risk factors. Case-control
studies can be carried out within a geo-
graphically specified population, a hospital
or clinic or a group ofhospitals or clinics,
or an exposure cohort.
This analysis is based on the published
papers ofpopulation-based or hospital-based
case-control studies of multiple myeloma
that provide risk ratios examining the fre-
quencies ofreported exposures to benzene
or to surrogates ofbenzene exposure.
Disease Outcome
Multiple myeloma is a clearly defined
malignant neoplasm ofthe plasma cell char-
acterized by at least two of the following
three diagnostic criteria: plasma cell infil-
tration in bone marrow smears or secre-
tions, definite osteolytic lesions in skeletal
X-rays, and monoclonal paraproteins in the
serum or urine. Most population-based
and hospital-based case-control studies
involve multiple myeloma cases in which
this diagnosis has been clinically confirmed
by pathological and/or clinical review. This
is in contrast to cohort studies whose crite-
ria for diagnosis are usually limited to
information from the death certificate.
Multiple myeloma cases have been coded
as 203 in the International Classification of
Environmental Health Perspectives - Vol 104, Supplement 6 * December 1996
ill
1393BEZABEH ETAL.
Diseases, Revisions 6 to 8 (ICD), 203.0 in
the ICD, Revision 9, and C90.0 in the
ICD, Revision 10.
ExposureDefinition
Analysis has been conducted using data
from the studies that specified benzene as
an exposure variable. Few studies did so.
Some studies reported data for larger chem-
ical categories that specifically included
benzene, such as solvent/benzene or aro-
matic hydrocarbons (benzene, toluene,
xylene, creosote). Persons included in the
categories ofexposures to solvents/benzene
(or solvents including benzene) or to aro-
matic hydrocarbons would include those
specifically reported as exposed to benzene
as well as those whose specific exposure was
to a different chemical in that chemical
category. Data from some studies present
risks associated with exposures to more
broadly defined mixtures ofchemicals that
include benzene. These data are used as
surrogates for benzene exposure. They
included benzene as a component ofgaso-
line and other petroleum products, ben-
zene as a component of engine exhaust
(product of combustion of carbonaceous
material), and occupational titles expected
to involve exposure to such products. These
occupational titles include refinery workers,
gas station workers, and mechanics. Benzene
exposure surrogates were grouped as petro-
leum products and constituents, engine
exhaust (diesel, gasoline, or unspecified),
and petroleum-related employments. The
methodology for collecting and interpret-
ing information for exposure ascertainment
has varied among the studies.
SearhStrateg
A literature search was performed looking
for population-based and hospital-based
multiple myeloma case-control studies that
considered occupational and environmen-
tal exposures as possible risk factors.
Studies that included information on ben-
zene exposures, surrogates for benzene
exposure, or occupational job titles proba-
bly associated with benzene exposure were
sought. The search was conducted using
MEDLINE for the years 1966 to 1995 as
well as the Occupational Medicine Digest
and references cited in identified articles.
This search method yielded the follow-
ing 13 case-control, population-based, or
hospital-based multiple myeloma studies
that contained odds ratio or risk ratio
analyses for occupational exposures (Table
1). None ofthe studies contained informa-
tion on actual measured exposures; all
Table 1. Population-based and hospital-based case-control studies of multiple myeloma.
No. Study Population Reference
1 Australia Tasmania Population Registry Giles et al. (8)
2 Canada Vancouver Clinic (1972-1981) Gallaher et al. (9)
3 Denmark - F Danish Cancer Registry (women) Pottern et al. (10)
4 Denmark - M Danish Cancer Registry (men) Heineman et al. (11)
5 England/Wales Referral centers (six areas) Cuzick et al. (12)
6 Italy Greater Milan area hospitals La Vecchia et al. (13)
7 Sweden - 1 Mid and SE Sweden hospital registries Flodin et al. (14)
8 Sweden - 2 Swedish Cancer Registry (1961-1979) McLaughlin et al. (15)
9 Sweden - 3 Four northern counties cancer registry Eriksson et al. (16)
10 United States - 1 Baltimore, MD, hospitals (whites) Linet et al. (17)
11 United States - 2 American Cancer Society - CPS Ila Boffetta et at. (18)
12 United States - 3 SEER Cancer Registries (fourareas)a Morris et al. (19);
Demers et al. (20)
13 United States -4 Death certificates (24 states) Figgs et al. (21)
aCPS, Cancer Prevention Study.
reported exposure classifications on the
basis ofinterview responses or employment
information. In some cases, industrial
hygienists assessed the likelihood ofspecific
exposures based on available information.
Analysis by exposure groupings that might
represent exposure to benzene or might be
surrogates for exposure to benzene were
extracted. The analytic results have been
organized into four groups:
* benzene and benzene-specified exposures:
benzene (two studies), solvent/benzene
(four), aromatichydrocarbons (one)
* petroleum products or constituents:
gasoline (one), petroleum products
(one), and oil products (one)
* petroleum products employment: auto
mechanic (one), refinery worker (two),
and gasoline station/garage worker (two)
* petroleum combustion products:
engine exhausts (five), diesel exhausts
(one), and gasoline exhausts (one).
Within these 13 studies, 20 odds ratios
were placed into the above groupings.
Results
Thirteen studies were found that met the
criteria for this analysis. Odds ratios or risk
ratios for exposure to benzene or to surro-
gates for benzene exposure were identified
along with their 95% confidence limits
where possible (Figure 1). Two of the
studies (11,17) cited benzene as an ana-
lyzed exposure. Three of the studies
(10,14,19) specified exposures to a chemi-
cal group that included benzene. The other
studies cited various surrogates for benzene
exposure as analyzed exposures.
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BenzeneExposures
Benzene. Linet et al. (17) reported an
adjusted matched odds ratio of 1.2 (95%
CI, 0.4-3.6) for multiple myeloma and
benzene exposure for 100 Baltimore,
Maryland (1975-1982), hospital cases and
their controls. Occupational exposures had
been directly inquired about in a tele-
phone questionnaire, as had occupational
and medical histories. Most ofthe respon-
ders for multiple myeloma cases were
proxy responders (spouses, children, or
siblings), as the case was either deceased or
too ill to be interviewed; most of the
responders for the controls were the
patients themselves. Their reported crude
matched odds ratio without the adjust-
ment for respondent's status (e.g., selfvs
proxy) was 1.1 (95% CI, 0.4-3.7).
Heineman et al. (11) reported an age-
adjusted odds ratio of0.8 (95% CI, 0.6-1.1)
for multiple myeloma and probable ben-
zene exposure for 1098 male Danish cases
registered in the Danish Cancer Registry
(1970-1984) and their matched live popu-
lation controls. Exposure assessments for
20 major categories of substances and 27
specific substances were made by industrial
hygienists using a four-strata classification
(none, possible, probable, or unknown)
based on employment histories in the
records of the Danish Supplementary
Pension Fund.
These studies reported odds ratios that
were approximately 1 (range 0.8-1.2),
indicating no evidence of an increased
association between multiple myeloma and
benzene exposure.
Solvents/Benzene. Flodin et al. (14)
published a hospital-based case referent
study based on 131 multiple myeloma cases
diagnosed in middle and southeast Sweden
between 1973 and 1983 and interviewed
between 1981 and 1983. Exposure was
assessed from the responses on a mailed
questionnaire. The crude rate ratio for sol-
vent exposure (including benzene, per per-
sonal communication) was 1.0 (0.59-1.8).
Pottern et al. (10) published a study for
1010 female Danish multiple myeloma
cases and their matched controls [a com-
panion study to the Heineman et al.
study of male Danish multiple myeloma
cases and controls (11)] and reported an
odds ratio of 0.8 (confidence limits not
reported) for exposure to solvents including
benzene. Pottern (10) and Heineman et al.
(11) used the same methodology for ascer-
taining exposure, i.e., exposure assignment
by industrial hygienists based on national
records ofpatients' employment histories.
Two studies examined for evidence ofa
linear trend with duration of exposure to
solvents including benzene without calcu-
lating an odds ratio for those with expo-
sure. Cuzick et al. (12) found neither an
excess risk for solvents including benzene
nor a linear trend for duration ofexposure
among their 399 cases and matched hospi-
tal controls from England and Wales. Cases
and controls were matched by age, gender,
and source ofmedical care. Exposure histo-
ries were obtained by interviewers using a
detailed questionnaire. Percentages ofcases
and controls having 1 to 10 years ofexpo-
sure and having greater than 10 years of
exposure were reported. La Vecchia et al.
(13) reported a case-control study oflym-
phoid neoplasms in which data for 110
multiple myeloma cases and 396 controls
were compared. Occupational histories
were obtained from the patients by trained
interviewers using a structured interview. A
significant positive linear trend for dura-
tion (<1 year, 1-10 years, and >10 years)
of exposure to solvents/benzene was
reported for multiple myelomas after the
data were adjusted for age and gender.
Analysis of the crude data did not show a
significant trend.
Aromatic Hydrocarbons. Morris et al.
(19) reported an adjusted odds ratio of
0.6 (95% CI 0.3-1.0) for multiple mye-
loma and exposure to aromatic hydro-
carbons based on 698 cases from selected
Surveillance, Epidemiology, and End
Result (SEER) Registries. These cases had
been registered as residents oftwo counties
in Washington State (King and Pierce),
three counties in Utah State (Davis, Salt
Lake, and Weber), or the metropolitan
areas of Detroit, Michigan, and Atlanta,
Georgia, for mid-1977 to mid-1981.
Aromatic hydrocarbons included benzene,
toluene, xylene, and creosote. Occupational
histories were obtained by trained inter-
viewers using a standardized questionnaire.
Categorization of responses was deter-
mined by a toxicologist not familiar with
the case-control status of the participant.
The adjusted odds ratio had been adjusted
for age, sex, race, and study site. Morris
et al. (19) also reported an adjusted odds
ratio for aromatic hydrocarbon exposure
when the data were from the self-respon-
dent cases with controls. This adjusted
odds ratio was 0.8 (95% CI, 0.5-1.4).
BenzeneSurrogates
Surrogates for benzene exposures have
been grouped into petroleum products,
petroleum combustion products, and
petroleum-related employment. The odds
ratios are shown both by central tendency
(ie., odds ratio) and by dispersion (i.e.,
95% confidence limits).
Petroleum Products
Gasoline. Heinemen et al. (11) reported
an adjusted odds ratio of 1.4 (95% CI
0.9-2.1) for multiple myeloma and proba-
ble benzene exposure among Danish men
diagnosed between 1970 and 1984.
Petroleum Products. Two studies
examined the association between petro-
leum products and multiple myeloma.
Linet et al. (17) found a statistically signifi-
cant increased adjusted odds ratio of 3.7
(95% CI 1.3-10.3) for petroleum exposure
in an analysis of matched cases and con-
trols. Heineman et al. (11) reported an
age-adjusted odds of 1.4 (95% CI 1.0-1.9)
for exposure to oil products.
Petroleum Combustion Products
Engine Exhaust. Four Scandinavian
studies have examined the association
between multiple myeloma and exposure
to engine exhaust. Flodin et al. (14) found
a statistically significant adjusted rate ratio
(Mantel-Haenszel point estimate) of 2.6
(95% CI 1.6-4.3) for engine exhaust in a
hospital-based case/referent study from
middle and south eastern Sweden. This
was a primary finding ofthe study, which
found significant associations for engine
exhaust, fresh wood, and creosote but not
for radiation. Eriksson et al. (16) reported
a rate ratio of 1.38 (90% CI 0.92-2.09)
for engine exhaust in a population-based
case-control study of 275 multiple mye-
loma cases diagnosed in residents of the
four most northern counties of Sweden
and registered in the Swedish Cancer
Registry between mid-1982 and mid-1986.
Eriksson included working with tractor
or power saw or working as a driver as
exposure to engine exhaust. Odds ratios for
probable engine exhaust exposure were
reported at 1.2 (95% CI 0.9-1.6) for
Danish men by Heineman et al. (11) and
at 1.6 (95% CI 0.4-5.5) for Danish
women by Pottern et al. (10) from popula-
tion-based case-control studies derived
from the 1970 to 1984 multiple myeloma
cases (1098 male and 1010 female cases) in
the Danish Cancer Registry.
Figgs et al. (21) in a study of death
certificates from 24 states reported signifi-
cantly increased mortality odds ratios for
certain groups ofworkers in certain occu-
pations associated with engines (bus driver,
stevedore, moving equipment supervisor,
Environmental Health Perspectives * Vol 104, Supplement 6 * December 1996 1 395BEZABEH ETAL.
and grader/dozer operator) and suggested
that exhaust exposure might be the associ-
ated factor. These mortality odds ratios
were generally about 2.5 with 95% confi-
dence ranges from about 1 to 6. However,
his most consistently elevated risk groups
were teachers, particularly elementary
school teachers.
Diesel Exhaust and Gasoline
Exhaust. Boffetta et al. (18) reported
Mantel-Haenszel matched odds ratios of
0.9 (95% CI 0.5-1.6) for gasoline exhaust
and of 1.4 (95% CI 0.7-2.7) for diesel
exhaust based on the 282 multiple myeloma
cases reported in the first 4 years offollow-
up of more than 500,000 male and
675,000 female enrollees in the American
Cancer Society (ACS) Cancer Prevention
Study II (CPS II). Exposure histories had
been obtained from personal interviews
conducted byvolunteers.
Employment-based Exposure
Reftnery Worker. Eriksson et al. (16)
reported a rate ratio of 1.00 (90% CI
0.10-10.06) for refinery workers in north-
ern Sweden, and McLaughlin et al. (15)
reported a standardized incidence ratio of
0.9 for petroleum refinery employment
in Sweden.
Auto Mechanic. Boffetta et al. (18)
reported a Mantel-Haenszel matched odds
ratio of0.9 (95% CI 0.2-3.5) for employ-
ment as an auto mechanic, based on the
data from the American Cancer Society
CPS II study.
Gasoline Station/Garage Worker.
Eriksson et al. (16) reported a rate ratio of
0.86 (90% CI 0.34-2.12) for employment
as a gasoline station/garage worker in the
northern Sweden study. Demers et al. (20),
in a new analysis of the SEER database
reported by Morris et al. (19), reported an
adjusted odds ratio of0.8 (95% CI 0.4-1.5)
for employment in garage and service
station occupations.
Discussion
Two case series and two epidemiological
studies reported associations between mul-
tiple myeloma and benzene exposure, thus
raising the hypothesis that benzene exposure
caused multiple myeloma. A search of the
epidemiological literature for hospital-based
or population-based case-control studies of
multiple myeloma cases was conducted
seeking information to test that hypothesis.
Two case-control studies reported odds
ratios specifically for benzene exposure.
Linet et al. (17), in a hospital-based study
from Baltimore, Maryland, reported an
odds ratio of 1.2 for benzene exposure with
a 95% confidence interval from 0.4 to 3.6.
Heineman et al. (11), in a population-based
study of Danish males, reported an odds
ratio of0.8 for probable benzene exposure
with a 95% confidence interval of 0.6 to
1.1. Both odds ratios approximated 1.
Heineman et al. (11) also reported an
odds ratio for possible benzene exposure of
1.3 with a 95 % confidence interval of 1.0
to 1.6. This borderline significant associa-
tion of 1.3 was found when the uncertain
benzene exposure category of "possible
exposure" was used, while no association
was found (0.8) when the more certain
benzene exposure category of "probable
exposure" was used. Heineman et al. (11)
further reported a trend toward a lower risk
of multiple myeloma with a greater dura-
tion of exposure to benzene. These obser-
vations are contrary to the expectations for
a causal relationship between multiple
myeloma and benzene exposure.
Three case-control studies reported
odds ratios specifically for exposure cate-
gories that included persons specified as
having benzene exposure (e.g., solvents or
aromatic hydrocarbons). These groups
would also include persons whose exposures
had been specified as being from a specific
substance other than benzene. Pottern et al.
(10) reported an odds ratio among Danish
female cases of 0.8 for exposure to any
organic solvents including benzene; Morris
et al. (19) reported an odds ratio of 0.6
(95% CI 0.3-1.0) for exposure to aro-
matic hydrocarbons, and Flodin et al.
(14) reported a risk ratio of 1.0 (95% CI
0.6-1.8) for exposure to solvent, a group-
ing that included benzene exposure (per-
sonal communication). The above studies
consistently show no association ofmulti-
ple myeloma in groups with or without
benzene-exposed workers (Figure 2).
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Figure 2. Odds ratio and 95% confidence limits for
multiple myeloma and benzene exposure.
Two studies examined for a linear trend
in the risk by duration ofexposure. Cuzick
et al. (12) showed a trend toward a lower
risk of multiple myeloma with a greater
duration of exposure to solvent/benzene,
and La Vecchia et al. (13) showed a risk
for solvent/benzene that was significantly
higher onlyafter age and gender adjustment
ofthe data.
In the absence of analyses specifically
for benzene exposure, analyses for surrogates
of benzene exposure have been reviewed.
Because major occupational exposures to
benzene come from petroleum products,
either directly or from their combustion
products, analyses relating to petroleum
products, petroleum combustion products,
or occupations with petroleum exposure
were assessed as surrogates for benzene
exposure. Odds ratios for exposures to
petroleum products [with one exception-
Linet et al. (17)] were not significantly
increased (i.e., 95 % lower confidence limit
> 1.0). Odds ratios for petroleum-related
employment rarely exceeded 1.0, and none
significantly. In contrast, odds ratios for
exposures to petroleum combustion prod-
uct tended to be somewhat elevated, with
two studies showing statistically significant
elevations (14,21).
Most studies that reported odds ratios
for multiple myelomas and benzene expo-
sure also reported odds ratios for multiple
myelomas and benzene surrogate expo-
sures. Linet et al. (17) reported a nonsigni-
ficant odds ratio for benzene exposure of
1.2 and a statistically significant odds ratio
of 3.7 for petroleum exposure. Heineman
et al. (11) reported a nonsignificant odds
ratio for probable benzene exposure of 0.8
and nonsignificant odds ratios for oil prod-
ucts and for gasoline exposures of 1.4.
Flodin et al. (14) reported a rate ratio of
1.0 for the category that included benzene
exposure (solvents) and a significantly ele-
vated rate ratio of2.3 for the benzene sur-
rogate exposure category ofengine exhaust.
Finally, Pottern et al. (10) reported a non-
significant odds ratio for probable benzene
exposure of 0.8 and a nonsignificant odds
ratio for engine exhaust of 1.6. Ifbenzene
exposure were the etiological agent expressed
by the odds ratio for the benzene surro-
gates, the odds ratio for the benzene expo-
sure would be expected to exceed the odds
ratio for the surrogate benzene exposure.
Since the opposite is observed (Figure 3), it
is unlikely that benzene exposure is the
explanatory factor.
The above analyses have demonstrated
that the population-based and hospital-based
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Figure 3. Odds ratio of multiple myeloma associated
with benzene and surrogate benzene exposure.
case-control studies for multiple myeloma
generally do not show a significant associa-
tion for benzene exposures, mixed benzene
exposures, petroleum products exposures,
or petroleum-related employments. These
results do not lead to a finding that benzene
is a cause ofmultiple myeloma.
Exposures to petroleum combustion
products, however, tend to have somewhat
elevated odds ratios, some ofwhich show
statistically significant elevations. Since
products ofcombustion consist of a wide
range ofcarcinogenic and noncarcinogenic
constituents, no particular constituent can
be positively distinguished. However, as in
the studies by Heineman et al. (11) and
Pottern et al. (10), the odds ratio for
probable benzene exposure was less than
1.0 and for probable engine exhaust or
exhaust gases was greater than 1.0; there-
fore benzene exposure, is unlikely to be the
explanatory factor.
The methodologies for exposure ascer-
tainment have varied among the studies.
Most studies begin with a work history ret-
rospectively obtained by interview (13),
telephone (17), or mail (14). Some studies
began with concurrently developed work
histories maintained bygovernment agencies
(11,14). Authors have used external evalua-
tors to categorize occupational information
based on the expertise ofa toxicologist (14)
or ofindustrial hygienists (11,14) or have
relied on the assessment ofthe interviewee
(17). The area ofvalidation of exposure
ascertainments is a developing field.
Cigarettes and automobiles are the
major sources ofhuman exposure to ben-
zene (22). Three ofthe case-control studies
(14,17,18) have been analyzed for multiple
myeloma risk from cigarette smoking. All
three found odds ratios that are less than
one (0.78, 0.8, and 0.9, respectively).
These results are consistent with the results
of most other studies that examined the
relationship between cigarette smoking and
multiple myeloma and found no associa-
tion (23-27) contra Mills et al. (28) in
contrast to the studies showing a relation-
ship between cigarette smoking and acute
myelogenous leukemia, which is known
to be related to benzene exposure. Since
cigarette smoking is often considered a
surrogate of benzene exposure in cancer
causation studies, this generally consistent
observation weighs against both benzene as
a causal agent and products ofcombustion
as a causal agent.
The causes of multiple myeloma are
not clear. The population-based and hospi-
tal-based case control studies of multiple
myelomas do not generally show consistent
patterns of excess risk for any particular
occupation or chemical exposure except
possibly for some aspect ofagriculture. A
number of researchers (9,12,13,15,16,18)
reported positive associations for farming
or agriculture. Others, however (19),
reported a positive association for pesticide;
and Linet et al. (17) found no association
with agriculture. Further, Linet et al. (17)
reported a significant association with
asbestos exposure; Morris et al. (19) and
Cuzick et al. (12) found nonsignificant
associations; and Boffetta et al. (18) found
a nonsignificant reduction. Occupations
generally not thought ofas associated with
marked chemical exposures frequently show
the strongest associations with multiple
myeloma. Giles et al. (8) found a signifi-
cant association only for cases that worked
in administrative occupations; Pottern
et al. (10) found the most significant asso-
ciations for women who worked in the
home (household help, mother's helper,
and "Mrs./homemaker"); and Figgs et al.
(21) found that teachers were the group
that most consistently had an elevated risk.
Among nonoccupational factors, Flodin et
al. (14) and Boffetta et al. (18) report a
significant positive association for diabetes
mellitus, but Gallaher et al. (8) and Cuzick
et al. (12) did not.
Thus, causal agents for multiple myeloma
have not been found. Nonetheless, in spite
ofthe reports from the 1970s and 1980s that
suggested an association between multiple
myeloma and benzene exposure, review of
the population-based and hospital-based
case-control studies in the mid-1990s reveal
that benzene exposure is unlikely to be a
causal agent for multiple myeloma. The
odds ratios for those studies that have exam-
ined benzene exposure are approximately
1.0. Exposures to chemicals in categories
containing benzene, exposures to petroleum
products, and employment in petroleum-
related occupations do not appear to be
risk factors for multiple myeloma. Products
ofcombustion described as "engine exhaust"
have a suggested association, while prod-
ucts ofcombustion described as "cigarette
smoking" do not, cigarette smoking often
being considered a surrogate for benzene
exposure. Much of the literature on risk
factors for multiple myeloma is ambivalent.
The current published case-control litera-
ture on benzene exposure is not ambivalent
and does not indicate that benzene exposure
is a risk factor for multiple myeloma.
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